Effect of different forms of vasoactive intestinal peptide on cAMP formation in the mammalian cerebral cortex

Polish Journal of Pharmacology

Volumn 56, Issue 4, 2004, Pages 421-425

  Dejda, Agnieszka ^a   Gendek Kubiak, Hanna ^b   Nowak, Jerzy Z ^a,b  

^a INSTITUTE OF MEDICAL BIOLOGY   (Poland)

^b MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Cerebral cortex; Chicken vasoactive intestinal peptide (cVIP); Cyclic adenosine 3',5' monophosphate (cAMP); Guinea pig; Guinea pig vasoactive intestinal peptide (gpVIP); Human; Porcine (mammalian) vasoactive intestinal peptide (mVIP); Rat; Vasoactive intestinal peptide (VIP)

Indexed keywords

CYCLIC AMP; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; SP 022212; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN SLICE; CHICKEN; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG POTENCY; GUINEA PIG; MALE; MAMMAL; NONHUMAN; NUCLEOTIDE METABOLISM; SPECIES DIFFERENCE; SWINE;

ANIMALS; CEREBRAL CORTEX; CHICKENS; CYCLIC AMP; DOSE-RESPONSE RELATIONSHIP, DRUG; GUINEA PIGS; HUMANS; MALE; RATS; SPECIES SPECIFICITY; SWINE; VASOACTIVE INTESTINAL PEPTIDE;

EID: 9744276031     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Ahren B, Alumets J, Ericson M, Fahrenkrug J, Fahrenkrug L, Hakanson R, Hedner P et al.: VIP occurs in intrathyroidal nerves and stimulates thyroid hormone secretion. Nature, 1980, 287, 343-345.
2. Aliakbari J, Sreedharan SP, Turck CW, Goetzl EJ: Selective localization of vasoactive intestinal peptide and substance P in human eosinophils. Biochem Biophys Res Commun, 1987, 148, 1440-1445.
3. Bailey CJ, Wilkes LC, Conlon JM, Armstrong PH, Buchanan KD: Effects of gastric inhibitory polypeptide, vasoactive intestinal polypeptide and peptide histidine isoleucine on the secretion of hormones by isolated mouse pancreatic islets. J Endocrinol, 1990, 125, 375-379.
4. Blank MA, Brown JR, Hunter JC, Bloom SR, Tyers MB: Effects of VIP and related peptides and Gila monster venom on genitourinary smooth muscle. Eur J Pharmacol, 1986, 132, 155-161.
5. Dalsgaard T, Hannibal J, Fahrenkrug J, Larsen CR, Ottesen B: VIP and PACAP display different vasodilatory effects in rabbit coronary and cerebral arteries. Regul Pept, 2003, 110, 179-188.
6. Dejda A, Matczak I, Nowak JZ: Peptide histidine-isoleucine (PHI) - from receptor to function (Polish). Działalnoś ć Naukowa PAN, 2003, 15, 126-128.
7. Dejda A, Matczak I, Wiktorowska-Owczarek A, Nowak JZ: Cyclic AMP formation in chicken brain: effect of vasoactive intestinal peptide, peptide histidine-isoleucine (PHI), and some PHI-related peptides. Pol J Pharmacol, 2003, 55, 747-751.
8. Delgado M, Abad C, Martinez C, Juarranz MG, Arranz A, Gomariz RP, Leceta J: Vasoactive intestinal peptide in the immune system: potential therapeutic role in inflammatory and autoimmune diseases. J Mol Med, 2002, 80, 16-24.
9. Du BH, Eng J, Hulmes JD, Chang M, Pan YCE, Yalow RS: Guinea pig has a unique mammalian VIP. Biochem Biophys Res Commun, 1985, 128, 1093-1098.
10. Eng J, Yu J, Rattan S, Yalow RS: Isolation and amino acid sequences of opossum vasoactive intestinal polypeptide and cholecystokinin octapeptide. Proc Natl Acad Sci USA, 1992, 89, 1809-1811.
11. Giachetti A, Said SI, Reynolds RC, Koniges FC: Vasoactive intestinal polypeptide in brain: localization in and release from isolated nerve terminals. Proc Natl Acad Sci USA, 1977, 74, 3424-3428.
12. Gourlet P, Vandermeers-Piret MC, Waelbroeck M: Vasoactive intestinal peptide modification at position 22 allows discrimination between receptor subtypes. Eur J Pharmacol, 1998, 348, 95-99.
13. Gozes I, Brenneman DE: VIP: molecular biology and neurobiological function. Mol Neurobiol, 1989, 3, 201-236.
14. Gozes I, Brenneman DE: A new concept in the pharmacology of neuroprotection. J Mol Neurosci, 2000, 14, 61-68.
15. Gozes I, Fridkin M, Hill JM, Brenneman DE: Pharmaceutical VIP: prospects and problems. Curr Med Chem, 1999, 6, 1019-1034.
16. Grider JR, Cable MB, Said SI, Makhlouf GM: Vasoactive intestinal peptide as a neural mediator of gastric relaxation. Am J Physiol, 1985, 248, G73-G78.
17. Harmar AJ, Arimura A, Gozes I, Journot L, Laburthe M, Pisegna JR, Rawlings SR et al.: IUPHAR XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide. Pharmacol Rev, 1998, 50, 265-270.
18. Kieffer TJ, Habener JF: The glucagon-like peptides. Endocr Rev, 1999, 20, 876-913.
19. Larsson LI, Fahrenkrug J, Holst JJ, Schaffalitzky De Muckadell OB: Innervation of the pancreas by vasoactive intestinal polypeptide (VIP) immunoreactive nerves. Life Sci, 1978, 22, 773-780.
20. Larsson LI, Fahrenkrug J, Schaffalitzky De Muckadell OB: Vasoactive intestinal polypeptide occurs in nerves of the female genitourinary tract. Science, 1977, 197, 1374-1375.
21. Larsson LI, Fahrenkrug J, Schaffalitzky De Muckadell O, Sundler F, Hakanson R, Rehfeld J R: Localization of vasoactive intestinal polypeptide (VIP) to central and peripheral neurons. Proc Natl Acad Sci USA, 1976, 73, 3197-3200.
22. Lundberg JM, Fahrenkrug J, Hokfelt T, Martling CR, Larsson O, Tatemoto K, Anggard A: Co-existence of peptide HI (PHI) and VIP in nerves regulating blood flow and bronchial smooth muscle tone in various mammals including man. Peptides, 1984, 5, 593-606.
23. 1 receptor agonist. J Biol Chem, 2000, 275, 24003-24012.
24. Nilsson A: Isolation, amino acid composition and terminal amino acid residues of the vasoactive octacosa-peptide from chicken intestine. Partial purification of chicken secretin. FEBS Lett, 1974, 47, 284-289.
25. Nowak JZ., Kuba K: Vasoactive intestinal peptide-stimulated adenosine 3′,5′-cyclic monophosphate formation in cerebral cortex and hypothalamus of chick and rat: comparison of the chicken and mammalian peptide. Neurosci Lett, 2001, 297, 93-96.
26. Nowak JZ, Kuba K, Zawilska JB: PACAP-induced formation of cyclic AMP in the chicken brain: regional variations and the effect of melatonin. Brain Res, 1999, 830, 195-199.
27. Nowak JZ, Sedkowska P, Zawilska JB, Gozes I, Brenneman DE: Antagonism of VIP-stimulated cyclic AMP formation in chick brain. J Mol Neurosci, 2003, 20, 163-171.
28. Nussdorfer GG, Malendowicz KL: The role of VIP, PACAP, and related peptides in the regulation of the hypothalamo-pituitary-adrenal axis. Peptides, 1998, 19, 1443-1467.
29. Polak JM, Bloom SR: Regulatory peptides and neuron-specific enolase in the respiratory tract of man and other mammals. Exp Lung Res, 1982, 3, 313-328.
30. Racusen LC, Binder MJ: Alteration of large intestinal electrolyte transport by vasoactive intestinal polypeptide in the rat. Gastroenterology, 1977, 73, 790-796.
31. Said SI: Vasoactive peptides in the lung, with special reference to vasoactive intestinal peptide. Exp Lung Res, 1982, 3, 343-348.
32. Said SI: Isolation, localization, and characterization of gastrointestinal peptides. Clin Biochem 1984, 17, 65-67.
33. Said SI, Mutt V: Polypeptide with broad biological activity: isolation from small intestine. Nature, 1970, 225, 863-864.
34. Salomon Y, Londos C, Rodbell M: A highly sensitive adenylate cyclase assay. Anal Biochem, 1974, 58, 541-548.
35. Samson WK, Said SI, McCann SM: Radioimmunologic localization of vasoactive intestinal polypeptide in hypothalamic and extrahypothalamic sites in the rat brain. Neurosci Lett, 1979, 12, 265-269.
36. Sherwood NM, Krueckl SL, McRory JE: The origin and function of the pituitary adenylate cyclase-activating polypeptide (PACAP)/glucagon superfamily. Endocr Rev, 2000, 21, 619-670.
37. Shimizu H, Daly JW, Creveling CR: A radioisotopic method for measuring the formation of adenosine 3′,5′-cyclic monophosphate in incubated slices of brain. J Neurochem, 1969, 16, 1609-1619.
38. Szecowka J, Lins PE, Tatemoto K, Efendic S: Effects of porcine heptacosapeptide and vasoactive intestinal polypeptide on insulin and glucagon secretion in rats. Endocrinology, 1983, 112, 1469-1473.